NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
25.50
+0.04 (0.16%)
Dec 20, 2024, 4:00 PM EST - Market closed
NAMS Market Cap
NAMS has a market cap or net worth of $2.36 billion as of December 20, 2024. Its market cap has increased by 217.96% in one year.
Market Cap
2.36B
Enterprise Value
1.93B
1-Year Change
217.96%
Ranking
Category
Stock Price
$25.50
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $2.36B, an increase of 1,425.32%. That is a compound annual growth rate of 102.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 2.36B | 156.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arrowhead Pharmaceuticals | 2.43B |
| Privia Health Group | 2.42B |
| Amneal Pharmaceuticals | 2.40B |
| Protagonist Therapeutics | 2.36B |
| Select Medical Holdings | 2.36B |
| Addus HomeCare | 2.32B |
| Centessa Pharmaceuticals | 2.31B |
| Ardent Health Partners | 2.29B |